Prognostic Value of Right Ventricular Afterload in Patients Undergoing Mitral Transcatheter Edge-to-Edge Repair.

mitral regurgitation mitral transcatheter edge‐to‐edge repair pulmonary effective arterial elastance pulmonary hypertension right ventricular afterload

Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
03 Apr 2024
Historique:
medline: 3 4 2024
pubmed: 3 4 2024
entrez: 3 4 2024
Statut: aheadofprint

Résumé

Pulmonary hypertension (PH) and secondary mitral regurgitation (MR) are associated with adverse outcomes after mitral transcatheter edge-to-edge repair. We aim to study the prognostic value of invasively measured right ventricular afterload in patients undergoing mitral transcatheter edge-to-edge repair. We identified patients who underwent right heart catheterization ≤1 month before transcatheter edge-to-edge repair. The end points were all-cause mortality and a composite of mortality and heart failure hospitalization at 2 years. Using the receiver operating characteristic curve-derived threshold of 0.6 for pulmonary effective arterial elastance ([Ea], pulmonary artery systolic pressure/stroke volume), patients were stratified into 3 profiles based on PH severity (low elastance [HE]: Ea <0.6/mean pulmonary artery pressure (mPAP)) <35; High Elastance with No/Mild PH (HE-): Ea ≥0.6/mPAP <35; and HE with Moderate/Severe PH (HE+): Ea ≥0.6/mPAP ≥35) and MR pathogenesis (Primary MR [PMR])/low elastance, PMR/HE, and secondary MR). The association between this classification and clinical outcomes was examined using Cox regression. Among 114 patients included, 50.9% had PMR. Mean±SD age was 74.7±10.6 years. Patients with Ea ≥0.6 were more likely to have diabetes, atrial fibrillation, New York Heart Association III/IV status, and secondary MR (all Assessment of the preprocedural cardiopulmonary profile based on mPAP, MR pathogenesis, and Ea guides patient selection by identifying hemodynamic features that indicate likely benefit from mitral-transcatheter edge-to-edge repair in PH or lack thereof.

Sections du résumé

BACKGROUND BACKGROUND
Pulmonary hypertension (PH) and secondary mitral regurgitation (MR) are associated with adverse outcomes after mitral transcatheter edge-to-edge repair. We aim to study the prognostic value of invasively measured right ventricular afterload in patients undergoing mitral transcatheter edge-to-edge repair.
METHODS AND RESULTS RESULTS
We identified patients who underwent right heart catheterization ≤1 month before transcatheter edge-to-edge repair. The end points were all-cause mortality and a composite of mortality and heart failure hospitalization at 2 years. Using the receiver operating characteristic curve-derived threshold of 0.6 for pulmonary effective arterial elastance ([Ea], pulmonary artery systolic pressure/stroke volume), patients were stratified into 3 profiles based on PH severity (low elastance [HE]: Ea <0.6/mean pulmonary artery pressure (mPAP)) <35; High Elastance with No/Mild PH (HE-): Ea ≥0.6/mPAP <35; and HE with Moderate/Severe PH (HE+): Ea ≥0.6/mPAP ≥35) and MR pathogenesis (Primary MR [PMR])/low elastance, PMR/HE, and secondary MR). The association between this classification and clinical outcomes was examined using Cox regression. Among 114 patients included, 50.9% had PMR. Mean±SD age was 74.7±10.6 years. Patients with Ea ≥0.6 were more likely to have diabetes, atrial fibrillation, New York Heart Association III/IV status, and secondary MR (all
CONCLUSIONS CONCLUSIONS
Assessment of the preprocedural cardiopulmonary profile based on mPAP, MR pathogenesis, and Ea guides patient selection by identifying hemodynamic features that indicate likely benefit from mitral-transcatheter edge-to-edge repair in PH or lack thereof.

Identifiants

pubmed: 38567665
doi: 10.1161/JAHA.123.033510
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e033510

Auteurs

Rody G Bou Chaaya (RG)

Houston Methodist DeBakey Heart and Vascular Center Houston TX.

Taha Hatab (T)

Houston Methodist DeBakey Heart and Vascular Center Houston TX.

Sahar Samimi (S)

Houston Methodist DeBakey Heart and Vascular Center Houston TX.

Fatima Qamar (F)

Houston Methodist DeBakey Heart and Vascular Center Houston TX.

Chloe Kharsa (C)

Houston Methodist DeBakey Heart and Vascular Center Houston TX.

Joe Aoun (J)

Houston Methodist DeBakey Heart and Vascular Center Houston TX.

Nadeen Faza (N)

Houston Methodist DeBakey Heart and Vascular Center Houston TX.

Stephen H Little (SH)

Houston Methodist DeBakey Heart and Vascular Center Houston TX.

Marvin D Atkins (MD)

Department of Cardiovascular Surgery Houston Methodist Hospital Houston TX.

Michael J Reardon (MJ)

Department of Cardiovascular Surgery Houston Methodist Hospital Houston TX.

Neal S Kleiman (NS)

Houston Methodist DeBakey Heart and Vascular Center Houston TX.

Sherif F Nagueh (SF)

Houston Methodist DeBakey Heart and Vascular Center Houston TX.

William A Zoghbi (WA)

Houston Methodist DeBakey Heart and Vascular Center Houston TX.

Ashrith Guha (A)

Houston Methodist DeBakey Heart and Vascular Center Houston TX.

Syed Zaid (S)

Department of Cardiology Baylor School of Medicine and the Michael E DeBakey VAMC Houston TX.

Sachin S Goel (SS)

Houston Methodist DeBakey Heart and Vascular Center Houston TX.

Classifications MeSH